MD Anderson researchers use supercomputers at the Texas Advanced Computing Center to develop, test treatment target identification tool for head and neck cancers
Before performing radiation therapy, radiation oncologists first carefully review medical images of the patient to identify the gross tumor volume, the observable portion of the disease. They then design patient-specific clinical target volumes that include surrounding tissues, since these regions can hide cancerous cells and provide pathways for metastasis.
Known as contouring, this process establishes how much radiation a patient will receive and how it will be delivered. In the case of head and neck cancer, this is a particularly sensitive task due to the presence of vulnerable tissues in the vicinity.
Though it may sound straightforward, contouring clinical target volumes is quite subjective. A recent study from Utrecht University found wide variability in how trained physicians contoured the same patient’s computed tomography (CT) scan, leading some doctors to suggest high-risk clinical target volumes eight times larger than their colleagues.
This inter-physician variability is a problem for patients, who may be over- or under-dosed based on the doctor they work with. It is also a problem for determining best practices, so standards of care can emerge.
Recently, Carlos Cardenas, a graduate research assistant and PhD candidate at The University of Texas MD Anderson Cancer Center in Houston, Texas, and a team of researchers at MD Anderson, working under the supervision of Laurence Court with support from the National Institutes of Health, developed a new method for automating the contouring of high-risk clinical target volumes using artificial intelligence and deep neural networks.
They report their results in the June 2018 issue of the International Journal of Radiation Oncology*Biology*Physics.
Cardenas’ work focuses on translating a physician’s decision-making process into a computer program. “We have a lot of clinical data and radiation therapy treatment plan data at MD Anderson,” he said. “If we think about the problem in a smart way, we can replicate the patterns that our physicians are using to treat specific types of tumors.”
In their study, they analyzed data from 52 oropharyngeal cancer patients who had been treated at MD Anderson between January 2006 to August 2010, and had previously had their gross tumor volumes and clinical tumor volumes contoured for their radiation therapy treatment.
Cardenas spent a lot of time observing the radiation oncology team at MD Anderson, which has one of the few teams of head and neck subspecialist oncologists in the world, trying to determine how they define the targets.
“For high-risk target volumes, a lot of times radiation oncologists use the existing gross tumor disease and apply a non-uniform distance margin based on the shape of the tumor and its adjacent tissues,” Cardenas said. “We started by investigating this first, using simple distance vectors.”
Cardenas began the project in 2015 and had quickly accumulated an unwieldy amount of data to analyze. He turned to deep learning as a way of mining that data and uncovering the unwritten rules guiding the experts’ decisions.
The deep learning algorithm he developed uses auto-encoders — a form of neural networks that can learn how to represent datasets — to identify and recreate physician contouring patterns.
The model uses the gross tumor volume and distance map information from surrounding anatomic structures as its inputs. It then classifies the data to identify voxels — three-dimensional pixels — that are part of the high-risk clinical target volumes. In oropharyngeal cancer cases, the head and neck are usually treated with different volumes for high, low and intermediate risk. The paper described automating the target for the high-risk areas. Additional forthcoming papers will describe the low and intermediate predictions.
Cardenas and his collaborators tested the method on a subset of cases that had been left out of the training data. They found that their results were comparable to the work of trained oncologists. The predicted contours agreed closely with the ground-truth and could be implemented clinically, with only minor or no changes.
In addition to potentially reducing inter-physician variability and allowing comparisons of outcomes in clinical trials, a tertiary advantage of the method is the speed and efficiency it offers. It takes a radiation oncologist two to four hours to determine clinical target volumes. At MD Anderson, this result is then peer reviewed by additional physicians to minimize the risk of missing the disease.
Using the Maverick supercomputer at the Texas Advanced Computing Center (TACC), they were able to produce clinical target volumes in under a minute. Training the system took the longest amount of time, but for that step too, TACC resources helped speed up the research significantly.
“If we were to do it on our local GPU [graphics processing unit], it would have taken two months,” Cardenas said. “But we were able to parallelize the process and do the optimization on each patient by sending those paths to TACC and that’s where we found a lot of advantages by using the TACC system.”
“In recent years, we have seen an explosion of new projects using deep learning on TACC systems,” said Joe Allen, a Research Associate at TACC. “It is exciting and fulfilling for us to be able to support Carlos’s research, which is so closely tied to real medical care.”
The project is specifically intended to help low-and-middle income countries where expertise in contouring is rarer, although it is likely that the tools will also be useful in the U.S.
Cardenas says such a tool could also greatly benefit clinical trials by allowing one to more easily compare the outcomes of patients treated at two different institutions.
Speaking about the integration of deep learning into cancer care, he said: “I think it’s going to change our field. Some of these recommender systems are getting to be very good and we’re starting to see systems that can make predictions with a higher accuracy than some radiologists can. I hope that the clinical translation of these tools provides physicians with additional information that can lead to better patient treatments.”
Learn more: AN AI ONCOLOGIST TO HELP CANCER PATIENTS WORLDWIDE
The Latest on: Deep learning in cancer care
[google_news title=”” keyword=”deep learning in cancer care” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Deep learning in cancer care
- Pisces and Cancer Compatibility: Are They a Good Match in Love and Friendship?on March 24, 2023 at 10:30 am
That said, Pisces and Cancer are more than just compatible signs; they can also share a deep bond that is often hard to define but easy to feel. Interested in learning more about ... and may feel like ...
- The power of machine learning in prostate cancer imagingon March 24, 2023 at 6:32 am
Researchers at Sylvester Comprehensive Cancer Center and the Desai Sethi Urology Institute are pioneering research to harness machine learning for the diagnosis and prognosis of prostate cancer, using ...
- AI, machine learning helping India fight against tuberculosison March 23, 2023 at 11:35 pm
Advances in medical technologies, that came with the inclusion of Artificial Intelligence (AI), Machine Learning, Internet of Things (IoT), and deep tech, have revolutionised diagnosis of tuberculosis ...
- Smart needles may cut down on surgeries: What to knowon March 23, 2023 at 2:19 pm
Smart needles could help reduce the need for typical cancer treatments such as invasive surgery, radiation or chemotherapy. Kurt "CyberGuy" Knutsson explains.
- Toxic trade-offson March 17, 2023 at 2:00 am
While advances in immunotherapy have dramatically improved cancer survival, unleashing the immune system can lead to a host of adverse reactions. How can patients pay less of a price?
- A Daughter's Love Song For Her Mother, Facing Cancer: 'My Mom Is Life'on March 16, 2023 at 5:17 pm
When she got the call that her mom's cancer was back, she said: 'I was that 15-year-old kid again, and my world was crumbling beneath me." ...
- Can healthcare show the way forward for scaling AI?on March 15, 2023 at 3:59 pm
Leading-edge, cloud-based approaches that might offer blueprints for other industries struggling with scaling automation.
- Scientists discover key information about the function of mitochondria in cancer cellson March 15, 2023 at 8:59 am
Scientists have long known that mitochondria play a crucial role in the metabolism and energy production of cancer cells. However, until now, little was known about the relationship between the ...
- Systematic Review of Privacy-Preserving Distributed Machine Learning From Federated Databases in Health Careon May 4, 2022 at 10:28 pm
Big data for health care is one of the potential ... post-radiotherapy dyspnea for patients with lung cancer) by learning from data stored within clinics without sharing any of the medical data. The ...
via Bing News